Microwave assisted synthesis of negative-charge carbon dots with potential antibacterial activity against multi-drug resistant bacteria
In this research, negative-charge carbon dots (CDs) were synthesized in one-step using a microwave and found to have potential antibacterial ability against multi-drug resistant bacteria. The CDs were synthesized by using citric acid and urea as precursors, and characterized by FT-IR, TEM and fluore...
Gespeichert in:
Veröffentlicht in: | RSC advances 2020-11, Vol.1 (67), p.4122-4128 |
---|---|
Hauptverfasser: | , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | In this research, negative-charge carbon dots (CDs) were synthesized in one-step using a microwave and found to have potential antibacterial ability against multi-drug resistant bacteria. The CDs were synthesized by using citric acid and urea as precursors, and characterized by FT-IR, TEM and fluorescence spectrophotometry. The average size of CDs was about 2.5 nm, and the
ζ
potential was −11.06 mV. In the following antibacterial activity test, time-killing curve experiments and colony-forming assay were carried out to determine the minimum bactericidal concentration (MBC) and minimum inhibitory concentration (MIC) of the CDs against methicillin-resistant
Staphylococcus aureus
(MRSA) and vancomycin-intermediate
Staphylococcus aureus
(VISA). The data showed the MBC of the CDs against MRSA is 2.5 mg mL
−1
, and the MIC of the CDs against MRSA is 0.63 mg mL
−1
; the MBC of the CDs against VISA is 1.25 mg mL
−1
, and the MIC of the CDs against VISA is 0.63 mg mL
−1
. The results demonstrated that the negative-charge CDs have potential against multi-drug resistant
Staphylococcus aureus
(
S. aureus
), and may serve as alternatives for therapy in the future.
In this research, negative-charge carbon dots (CDs) were synthesized in one-step using a microwave and found to have potential antibacterial ability against multi-drug resistant bacteria. |
---|---|
ISSN: | 2046-2069 2046-2069 |
DOI: | 10.1039/d0ra07106d |